Armata Pharmaceuticals Inc

ASE:ARMP  
3.04
-0.06 (-1.94%)
Earnings Announcements

Armata Pharmaceuticals Posts Q4 Revenue $500,000

Published: 03/18/2021 21:36 GMT
Armata Pharmaceuticals Inc (ARMP) - Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update.
Q4 Revenue $500,000.
Q4 Revenue Estimate $703,000 -- Refinitiv Ibes Data (analyst estimates).
Quarterly Loss per Share $0.36.
Revenue is expected to be $1.08 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $1.1 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.